FRI0296 The Optimal Modified Rodnan Skin Score To Predict Skin Progression over One Year Differs between Autoantibody Subsets
BackgroundThere are muliple potential therapeutic a gents under development for sstemic sclerosis (SSc). Given that SSc is uncommon, there is interest in cohort enrichment to maximize the potential of identifying a drug effect, One area of interest is a modified Rodnan skin score (mRSS) cut-off as a...
Gespeichert in:
| Veröffentlicht in: | Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.542 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!